- Home
- INCR vs OKUR Comparison
INCR vs OKUR Comparison
Compare INCR & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- OKUR
- Stock Information
- Founded
- INCR 1994
- OKUR 2011
- Country
- INCR Israel
- OKUR United States
- Employees
- INCR N/A
- OKUR N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- OKUR
- Sector
- INCR Health Care
- OKUR
- Exchange
- INCR Nasdaq
- OKUR NYSE
- Market Cap
- INCR 84.5M
- OKUR 34.9M
- IPO Year
- INCR N/A
- OKUR N/A
- Fundamental
- Price
- INCR $1.48
- OKUR $2.40
- Analyst Decision
- INCR
- OKUR Strong Buy
- Analyst Count
- INCR 0
- OKUR 4
- Target Price
- INCR N/A
- OKUR $32.25
- AVG Volume (30 Days)
- INCR 16.3K
- OKUR 73.0K
- Earning Date
- INCR 08-15-2025
- OKUR 08-14-2025
- Dividend Yield
- INCR N/A
- OKUR N/A
- EPS Growth
- INCR N/A
- OKUR N/A
- EPS
- INCR N/A
- OKUR N/A
- Revenue
- INCR $65,575,323.00
- OKUR N/A
- Revenue This Year
- INCR $69.54
- OKUR N/A
- Revenue Next Year
- INCR $41.75
- OKUR N/A
- P/E Ratio
- INCR N/A
- OKUR N/A
- Revenue Growth
- INCR N/A
- OKUR N/A
- 52 Week Low
- INCR $1.17
- OKUR $1.70
- 52 Week High
- INCR $2.62
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- INCR 45.71
- OKUR N/A
- Support Level
- INCR $1.43
- OKUR N/A
- Resistance Level
- INCR $1.50
- OKUR N/A
- Average True Range (ATR)
- INCR 0.06
- OKUR 0.00
- MACD
- INCR -0.00
- OKUR 0.00
- Stochastic Oscillator
- INCR 38.46
- OKUR 0.00
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.